Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

UBS
McKesson
Citi
QuintilesIMS
Fuji
Chubb
Chinese Patent Office
AstraZeneca
Express Scripts
Mallinckrodt

Generated: January 23, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,777,429

« Back to Dashboard

Summary for Patent: 6,777,429
Title: Ophthalmic composition
Abstract:The present invention is related to an ophthalmic composition comprising ketotifen as a pharmaceutically active agent.
Inventor(s): Adam; Marcia Johanna (Gisikon, CH), Fetz; Andrea (Wetzikon, CH), Kis; Gyorgy Lajos (Triboltingen, CH)
Assignee: Novartis AG (Basel, CH)
Application Number:09/619,349
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 6,777,429

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 6,777,429

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
99114508Jul 23, 1999

International Patents Family Members for US Patent 6,777,429

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia 6565500 ➤ Subscribe
Australia 775832 ➤ Subscribe
Brazil 0012696 ➤ Subscribe
Canada 2377024 ➤ Subscribe
China 1358086 ➤ Subscribe
Czech Republic 20020243 ➤ Subscribe
Czech Republic 300614 ➤ Subscribe
Estonia 05439 ➤ Subscribe
Estonia 200200040 ➤ Subscribe
European Patent Office 1198223 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Johnson and Johnson
US Department of Justice
Cantor Fitzgerald
Daiichi Sankyo
UBS
Moodys
Citi
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot